Foamix Pharmaceuticals Ltd. Total Liabilities and Equity
Foamix Pharmaceuticals Ltd. had Total Liabilities and Equity of $81.16 million as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2020-03-12
- 2019-12-31: Liabilities and Equity $81.16M.
- 2019-09-30: Liabilities and Equity $81.58M.
- 2019-06-30: Liabilities and Equity $76.23M.
- 2019-03-31: Liabilities and Equity $89.56M.
| Period end | Liabilities and Equity |
|---|---|
| 2019-12-31 | $81.16M 10-K · filed 2020-03-12 |
| 2019-09-30 | $81.58M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $76.23M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $89.56M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $103.73M 10-K · filed 2020-03-12 |
| 2018-09-30 | $115.19M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $60.07M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $56.47M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $80.25M 10-K · filed 2019-02-28 |
| 2017-06-30 | $112.39M 6-K · filed 2017-08-08 |
| 2016-12-31 | $135.63M 10-K · filed 2018-03-01 |
| 2016-06-30 | $92.84M 6-K · filed 2016-08-10 |
| 2015-12-31 | $105.25M 20-F · filed 2017-02-21 |
| 2015-06-30 | $111.92M 6-K · filed 2015-10-19 |
| 2014-12-31 | $51.28M 20-F · filed 2016-03-02 |
| 2013-12-31 | $3.09M 20-F · filed 2015-03-17 |